Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1038/s41598-018-30794-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug target residence time: a misleading concept
- (2018) Rutger H.A. Folmer DRUG DISCOVERY TODAY
- The preclinical discovery and development of cariprazine for the treatment of schizophrenia
- (2018) Anna Wesołowska et al. Expert Opinion on Drug Discovery
- BiKi Life Sciences: A New Suite for Molecular Dynamics and Related Methods in Drug Discovery
- (2018) Sergio Decherchi et al. Journal of Chemical Information and Modeling
- Fast Dynamic Docking Guided by Adaptive Electrostatic Bias: The MD-Binding Approach
- (2018) Andrea Spitaleri et al. Journal of Chemical Theory and Computation
- Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
- (2018) Sheng Wang et al. NATURE
- Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism
- (2017) Alessandro Bonifazi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Trends in GPCR drug discovery: new agents, targets and indications
- (2017) Alexander S. Hauser et al. NATURE REVIEWS DRUG DISCOVERY
- Binding Kinetics and Pathways of Ligands to GPCRs
- (2017) Andrea Strasser et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands
- (2017) Moritz Schübler et al. Frontiers in Chemistry
- The dopamine D3 receptor, a quarter century later
- (2016) Pierre Sokoloff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors
- (2016) Trayder Thomas et al. Journal of Chemical Information and Modeling
- The role of kinetic context in apparent biased agonism at GPCRs
- (2016) Carmen Klein Herenbrink et al. Nature Communications
- Rotigotine is a potent agonist at dopamine D1receptors as well as at dopamine D2and D3receptors
- (2015) Martyn Wood et al. BRITISH JOURNAL OF PHARMACOLOGY
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- Kinetics of protein-ligand unbinding via smoothed potential molecular dynamics simulations
- (2015) Luca Mollica et al. Scientific Reports
- A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
- (2014) David C Swinney et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
- (2014) Ralf Brisch et al. Frontiers in Psychiatry
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
- (2013) Sander Pronk et al. BIOINFORMATICS
- A general and Robust Ray-Casting-Based Algorithm for Triangulating Surfaces at the Nanoscale
- (2013) Sergio Decherchi et al. PLoS One
- Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors
- (2012) Éva Ágai-Csongor et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
- (2012) Georges Vauquelin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Bridging the gap: bitopic ligands of G-protein-coupled receptors
- (2012) J. Robert Lane et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release
- (2011) Lucia Carboni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Discovery of -Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
- (2011) J. A. Allen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
- (2010) E. Y. T. Chien et al. SCIENCE
- Antagonism of dopamine D2 receptor/ -arrestin 2 interaction is a common property of clinically effective antipsychotics
- (2008) B. Masri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started